In a lawsuit filed in September 2024, the FTC alleged that CVS Caremark, along with Express Scripts and OptumRx, used rebate systems that favored higher-cost drugs, driving up list prices and out-of-pocket costs for patients.

A new House bill would apply the penalty to insurers that reject more than 25% of claims.

The state has filed a complaint in the U.S. District Court for the District of Rhode Island that accuses the PBMs of violating the federal Deceptive Trade Practices Act.

A union health plan is suing in federal court and hopes to represent a class that will include self-insured employer plans.